US Congress Subject | Competition and antitrust

Filter View [Reset All]
Syndicate content
StanceStateBillStatusSummary/TitleLast Actionsort icon
USHB595IntroTo provide a cause of action for violations of laws related to COVID-19, and for other purposes.
[Detail][Text][Discuss]
2021-01-28
To House Judiciary Committee
USHB527IntroEstablishes the Office of Economic Analysis in the Consumer Financial Protection Bureau (CFPB) to review all proposed and existing guidance, orders, rules, and regulations. The CFPB must also identify in each proposed rulemaking the problem to be sol...
[Detail][Text][Discuss]
2021-01-28
To House Financial Services Committee
USSB68IntroA bill to amend chapter 8 of title 5, United States Code, to provide that major rules of the executive branch shall have no force or effect unless a joint resolution of approval is enacted into law.
[Detail][Text][Discuss]
2021-01-27
To Senate Homeland Security And Governmental Affairs Committee
USHB153IntroProhibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Specifically, such an agreemen...
[Detail][Text][Discuss]
2021-01-04
To House Energy And Commerce Committee
Syndicate content
feedback